Scientists test common vaccine on rare immune disease
NCT ID NCT03519464
Summary
This study is testing whether the Gardasil 9 HPV vaccine can help prevent HPV-related diseases in adults with a rare immune condition called Idiopathic CD4 T Cell Lymphocytopenia (ICL). People with ICL get more frequent and severe HPV infections. Researchers are giving the vaccine to 54 participants to see if their immune systems respond well and if it is safe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC CD4 T CELL LYMPHOCYTOPENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.